Iron is an essential mineral that is distributed throughout the body and is important for oxygen transport and cellular metabolism. Iron deficiency develops when requirements exceed supply and leads to iron deficient erythropoiesis and eventually iron deficiency anemia. It is one of the most common nutritional deficiencies worldwide, affecting toddlers, adolescent girls, pregnant women, and some minority groups. Treatment involves oral or parenteral iron supplementation depending on severity, with the goal of replenishing iron stores and repairing hemoglobin deficits.
This document discusses iron deficiency anemia, including its causes, stages, clinical features, diagnosis, and treatment. It notes that iron deficiency anemia is the most common type of anemia worldwide. The stages of iron deficiency progress from depletion of iron stores to latent deficiency to anemia when hemoglobin levels fall below normal. Causes include inadequate dietary iron intake, impaired absorption, and increased losses. Treatment involves dietary sources of iron as well as oral or parenteral iron supplements.
Iron deficiency anemia (IDA) is caused by not having enough iron available to make hemoglobin, limiting red blood cell and hemoglobin production and resulting in less oxygen delivery to tissues. IDA is common where meat intake is low and intestinal parasites are present. Symptoms include pallor, fatigue, and weakness. Studies in Saudi Arabia found IDA prevalence of 8.5-55.4% among children and 31.9-32% among pregnant women. Treatment involves iron supplementation and addressing underlying causes, while prevention focuses on iron-rich foods and supplements during pregnancy and breastfeeding.
Iron deficiency anemia is the most common nutritional disorder worldwide caused by inadequate iron intake or excessive iron loss. It develops in stages from depletion of iron stores to microcytic hypochromic anemia. Laboratory findings include low hemoglobin, serum ferritin and iron levels, as well as high TIBC. Peripheral smear shows microcytic hypochromic red blood cells. Bone marrow is hypercellular with iron deficiency and microcytic normoblastic erythropoiesis. Treatment involves oral or parenteral iron supplementation.
Iron Deficiency Anemia occurs when iron levels are too low to support normal red blood cell production. It has various causes like bleeding, low dietary iron intake, or loss of iron in the urine. Symptoms include fatigue and pale skin. Investigations show low hemoglobin, ferritin and iron levels with microcytic red blood cells. Treatment involves oral or intravenous iron supplementation depending on severity. Complications can include impaired development in children or increased risk of falls in the elderly. Prevention focuses on consuming iron-rich foods and supplements. Differential diagnoses include thalassemia and anemia of chronic disease.
- Iron is an essential trace element that is mainly present in blood, liver, bone marrow and muscles. It is required for hemoglobin, myoglobin and other protein synthesis.
- Iron deficiency anemia results from inadequate iron intake, absorption or increased losses and can be diagnosed based on low serum iron, ferritin and transferrin saturation along with microcytic hypochromic anemia.
- Treatment involves oral iron supplementation long-term or intravenous iron for severe cases. Blood transfusions are needed for acute blood loss.
This document discusses iron deficiency anemia, including its causes, signs and symptoms, diagnostic tests, and differential diagnosis. It notes that iron deficiency anemia is the most common cause of anemia and results from absent or decreased iron stores combined with low serum ferritin levels. The document outlines how iron is absorbed, transported, and stored in the body. It also lists common signs of iron deficiency anemia such as fatigue, angular stomatitis, and nail changes. Diagnostic tests discussed include complete blood count, serum iron, total iron binding capacity, serum ferritin, and bone marrow examination. Thalassemia, lead poisoning, and anemia of chronic disease are mentioned as conditions in the differential diagnosis.
Iron deficiency anemia is the most advanced stage of iron deficiency which is characterized not only by low hemoglobin and Hematocrit levels but also by a reduction or depletion of iron stores, by low serum iron levels and decreased transferrin saturation.
This document discusses iron deficiency anemia, including its causes, stages, clinical features, diagnosis, and treatment. It notes that iron deficiency anemia is the most common type of anemia worldwide. The stages of iron deficiency progress from depletion of iron stores to latent deficiency to anemia when hemoglobin levels fall below normal. Causes include inadequate dietary iron intake, impaired absorption, and increased losses. Treatment involves dietary sources of iron as well as oral or parenteral iron supplements.
Iron deficiency anemia (IDA) is caused by not having enough iron available to make hemoglobin, limiting red blood cell and hemoglobin production and resulting in less oxygen delivery to tissues. IDA is common where meat intake is low and intestinal parasites are present. Symptoms include pallor, fatigue, and weakness. Studies in Saudi Arabia found IDA prevalence of 8.5-55.4% among children and 31.9-32% among pregnant women. Treatment involves iron supplementation and addressing underlying causes, while prevention focuses on iron-rich foods and supplements during pregnancy and breastfeeding.
Iron deficiency anemia is the most common nutritional disorder worldwide caused by inadequate iron intake or excessive iron loss. It develops in stages from depletion of iron stores to microcytic hypochromic anemia. Laboratory findings include low hemoglobin, serum ferritin and iron levels, as well as high TIBC. Peripheral smear shows microcytic hypochromic red blood cells. Bone marrow is hypercellular with iron deficiency and microcytic normoblastic erythropoiesis. Treatment involves oral or parenteral iron supplementation.
Iron Deficiency Anemia occurs when iron levels are too low to support normal red blood cell production. It has various causes like bleeding, low dietary iron intake, or loss of iron in the urine. Symptoms include fatigue and pale skin. Investigations show low hemoglobin, ferritin and iron levels with microcytic red blood cells. Treatment involves oral or intravenous iron supplementation depending on severity. Complications can include impaired development in children or increased risk of falls in the elderly. Prevention focuses on consuming iron-rich foods and supplements. Differential diagnoses include thalassemia and anemia of chronic disease.
- Iron is an essential trace element that is mainly present in blood, liver, bone marrow and muscles. It is required for hemoglobin, myoglobin and other protein synthesis.
- Iron deficiency anemia results from inadequate iron intake, absorption or increased losses and can be diagnosed based on low serum iron, ferritin and transferrin saturation along with microcytic hypochromic anemia.
- Treatment involves oral iron supplementation long-term or intravenous iron for severe cases. Blood transfusions are needed for acute blood loss.
This document discusses iron deficiency anemia, including its causes, signs and symptoms, diagnostic tests, and differential diagnosis. It notes that iron deficiency anemia is the most common cause of anemia and results from absent or decreased iron stores combined with low serum ferritin levels. The document outlines how iron is absorbed, transported, and stored in the body. It also lists common signs of iron deficiency anemia such as fatigue, angular stomatitis, and nail changes. Diagnostic tests discussed include complete blood count, serum iron, total iron binding capacity, serum ferritin, and bone marrow examination. Thalassemia, lead poisoning, and anemia of chronic disease are mentioned as conditions in the differential diagnosis.
Iron deficiency anemia is the most advanced stage of iron deficiency which is characterized not only by low hemoglobin and Hematocrit levels but also by a reduction or depletion of iron stores, by low serum iron levels and decreased transferrin saturation.
Iron deficiency anemia is the most common type of anemia globally. It results from inadequate iron intake or absorption to meet physiological needs. Common symptoms include pallor, weakness, and fatigue. Diagnosis involves blood tests showing microcytic hypochromic anemia, low serum iron and ferritin levels, and high total iron binding capacity. Treatment consists of oral iron supplementation in the form of ferrous salts to replenish iron stores.
Iron deficiency anemia is the most common type of anemia worldwide. It occurs when iron levels in the body are low, preventing adequate hemoglobin production. Common causes include deficient diet, blood loss from menstruation or gastrointestinal issues, and increased needs during pregnancy or lactation. Symptoms include fatigue, palpitations, and pale skin. Diagnosis involves blood tests showing low ferritin, increased total iron-binding capacity, and transferrin saturation below 16%. Treatment focuses on oral iron supplementation, but parenteral iron may be used if oral iron is not tolerated or absorption is impaired.
Anemia is a decrease in red blood cells (RBCs), hemoglobin (Hgb), or hematocrit (HCT) levels compared to normal levels for age and sex. Anemias can be classified based on RBC size and hemoglobin content as normocytic normochromic, microcytic hypochromic, or macrocytic normocytic. Common causes of anemia include iron deficiency, anemia of chronic disease, thalassemia, vitamin B12 or folate deficiency, blood loss, and aplastic anemia.
Anemia is defined as a reduction in red blood cells or hemoglobin below healthy levels. Red blood cell production changes after birth as erythropoietin levels and the major production site shift from the fetal liver to the kidneys. Causes of anemia include decreased red blood cell production from deficiencies in vitamins like B12 and folate, increased red blood cell destruction, and acute blood loss. Megaloblastic anemia results from DNA synthesis defects caused by vitamin B12 or folate deficiencies. Folate deficiency can occur from poor diet, malabsorption, medications, or pregnancy and increases red blood cell size.
Iron deficiency anemia is one of the nutritional deficiency anemia, and the most common microcytic hypochromic anemia. it is also one of the common anemia in Pakistan. Pregnant and lactating are most commonly affected.
An 18-year-old female presented with symptoms of iron deficiency anemia including weakness, lethargy, and excessive bleeding during menstruation. On examination, she had pale skin and nail beds, swollen tongue, and tachycardia. Blood tests confirmed low hemoglobin, hematocrit, and iron levels. She was diagnosed with iron deficiency anemia based on her symptoms, physical exam findings, and blood test results. Treatment involved oral iron supplementation or parenteral iron therapy depending on severity. The goal of treatment was to raise hemoglobin levels and replenish iron stores.
Iron deficiency anemia is a common global health problem affecting 30% of the population. It causes decreased work productivity and increases maternal, child, and infant mortality. Good dietary sources of iron include liver, oats, legumes, and cashew nuts. Iron deficiency can be treated with oral iron supplements taken for 8 weeks, while severe cases may require intravenous iron or blood transfusions. Prevention strategies include iron fortification of infant formula and treating iron deficiency in at-risk groups like adolescent females.
Approach to a case of iron defciency anaemiaSachin Adukia
- Anaemia is defined as a reduction in haemoglobin, red blood cell count or haematocrit below normal levels. Iron-deficiency anaemia affects around 2 billion people worldwide including 20-40% of people in India.
- Iron-deficiency anaemia is classified based on the underlying cause such as reduced red blood cell production, increased red blood cell destruction, or loss of red blood cells.
- Diagnosis involves examination of symptoms, signs, and laboratory tests including a blood smear, iron studies, and bone marrow examination. Treatment involves oral or intravenous iron supplementation depending on the severity of the deficiency.
Iron is a mineral that is essential for the formation of hemoglobin in red blood cells. It serves several vital functions in the body including carrying oxygen from the lungs to tissues. Iron deficiency anemia is a condition where the body lacks sufficient red blood cells due to low iron levels, preventing adequate oxygen transport. It is one of the most common nutritional deficiencies worldwide, affecting groups like infants, children, pregnant women, and menstruating women the most. Symptoms include fatigue, pale skin, and shortness of breath.
Megaloblastic anemia is a type of macrocytic anemia caused by a failure of DNA synthesis, resulting in asynchronous maturation of red blood cell nuclei and cytoplasm. The most common causes of megaloblastic anemia are vitamin B12 and folic acid deficiencies. Treatment involves treating the underlying deficiency, with vitamin B12 therapy for B12 deficiency and oral folic acid supplementation for folic acid deficiency. Response to treatment is monitored through improvement of hematological markers and symptoms over 1-8 weeks.
The document discusses iron deficiency anemia, including its definition, symptoms, causes, stages, diagnostic tests, and treatment options. Key points include:
- Iron deficiency anemia is defined as a reduction in hemoglobin concentration below the reference value.
- Symptoms include fatigue, dizziness, and headaches. Specific symptoms like glossitis or koilonychia may also occur.
- Causes include chronic bleeding, decreased iron intake, and increased iron requirements during growth or pregnancy.
- Diagnosis involves blood tests measuring iron levels, iron binding capacity, ferritin, and a bone marrow smear.
- Treatment options include oral or parenteral iron supplementation to restore iron stores over 6-9
Anaemia, or anemia, is defined as an abnormally low number of red blood cells or level of hemoglobin resulting in diminished oxygen carrying capacity. It can result from blood loss, red blood cell destruction, or deficient red blood cell production due to nutritional deficiencies or bone marrow failure. Iron deficiency is a common worldwide cause of anemia affecting people of all ages, which can result from dietary deficiency, blood loss, or increased demands. The manifestations of iron deficiency anemia are related to impaired oxygen transport and include fatigue, paleness, rapid heartbeat, and reduced exercise endurance. Diagnosis involves low hemoglobin and iron levels, while treatment focuses on controlling blood loss, increasing iron intake, and administering iron supplements.
1. Iron deficiency anemia is a condition caused by low levels of iron in the body, which reduces the amount of oxygen carried by red blood cells.
2. Common causes of iron deficiency anemia include blood loss from menstruation or childbirth, a diet low in iron, and an inability to absorb enough iron from food.
3. Symptoms of iron deficiency anemia include fatigue, dizziness, pale skin, headaches, and brittle nails. Treatment involves oral or intravenous iron supplements to replace iron stores in the body.
The document discusses iron metabolism and disorders of iron deficiency. It covers stages of iron deficiency from depleted iron stores to iron deficiency anemia. Symptoms of iron deficiency anemia include fatigue, dizziness, and behavioral disturbances. Diagnosis involves low hemoglobin, mean corpuscular volume and other blood markers. Treatment focuses on oral or parenteral iron supplementation depending on severity and ability to absorb orally.
UAEU - CMHS - Hematology-Oncology Course - MMH 302 - HONC 320. Education material for medical students - It cover basic principles of hematology and oncology, including CAR-T and gene editing. It can be used for study and review. It illustrates main principles of hematology and oncology.
This document provides an overview of hemolytic anemia, including definitions, pathogenesis, classification, clinical features, laboratory findings, and approaches. Hemolytic anemia is characterized by increased red blood cell destruction. It can be hereditary or acquired. Specific hereditary forms discussed include hereditary spherocytosis, elliptocytosis, and pyropoikilocytosis, which are caused by red blood cell membrane defects. Clinical features may include pallor, jaundice, splenomegaly, and gallstones. Laboratory findings aid in diagnosis and include peripheral smear showing abnormal red blood cells, reticulocytosis, and elevated bilirubin. The document also discusses hemolytic anemia evaluation and differential diagnoses.
This document discusses iron deficiency anemia, including its causes, symptoms, signs, and laboratory investigations used to confirm and determine the cause of the condition. Iron deficiency anemia is the most common form of anemia and is caused by inadequate iron intake, blood loss, or malabsorption. Key lab tests to confirm include low hemoglobin, MCV, serum ferritin and transferrin saturation. Tests to determine the underlying cause include stool samples, endoscopy, and imaging of the gastrointestinal tract.
Megaloblastic anemias are caused by impaired DNA synthesis due to vitamin B12 or folate deficiency. The summary examines megaloblastic anemias, including causes such as vitamin B12 or folate metabolism defects, clinical features like pallor and neurological symptoms, investigation findings in peripheral blood and bone marrow showing megaloblasts and macroovalocytes, and treatment involving vitamin B12 or folate supplementation.
Iron deficiency anemia is the most common type of anemia globally. It results from inadequate iron intake or absorption to meet physiological needs. Common symptoms include pallor, weakness, and fatigue. Diagnosis involves blood tests showing microcytic hypochromic anemia, low serum iron and ferritin levels, and high total iron binding capacity. Treatment consists of oral iron supplementation in the form of ferrous salts to replenish iron stores.
Iron deficiency anemia is the most common type of anemia worldwide. It occurs when iron levels in the body are low, preventing adequate hemoglobin production. Common causes include deficient diet, blood loss from menstruation or gastrointestinal issues, and increased needs during pregnancy or lactation. Symptoms include fatigue, palpitations, and pale skin. Diagnosis involves blood tests showing low ferritin, increased total iron-binding capacity, and transferrin saturation below 16%. Treatment focuses on oral iron supplementation, but parenteral iron may be used if oral iron is not tolerated or absorption is impaired.
Anemia is a decrease in red blood cells (RBCs), hemoglobin (Hgb), or hematocrit (HCT) levels compared to normal levels for age and sex. Anemias can be classified based on RBC size and hemoglobin content as normocytic normochromic, microcytic hypochromic, or macrocytic normocytic. Common causes of anemia include iron deficiency, anemia of chronic disease, thalassemia, vitamin B12 or folate deficiency, blood loss, and aplastic anemia.
Anemia is defined as a reduction in red blood cells or hemoglobin below healthy levels. Red blood cell production changes after birth as erythropoietin levels and the major production site shift from the fetal liver to the kidneys. Causes of anemia include decreased red blood cell production from deficiencies in vitamins like B12 and folate, increased red blood cell destruction, and acute blood loss. Megaloblastic anemia results from DNA synthesis defects caused by vitamin B12 or folate deficiencies. Folate deficiency can occur from poor diet, malabsorption, medications, or pregnancy and increases red blood cell size.
Iron deficiency anemia is one of the nutritional deficiency anemia, and the most common microcytic hypochromic anemia. it is also one of the common anemia in Pakistan. Pregnant and lactating are most commonly affected.
An 18-year-old female presented with symptoms of iron deficiency anemia including weakness, lethargy, and excessive bleeding during menstruation. On examination, she had pale skin and nail beds, swollen tongue, and tachycardia. Blood tests confirmed low hemoglobin, hematocrit, and iron levels. She was diagnosed with iron deficiency anemia based on her symptoms, physical exam findings, and blood test results. Treatment involved oral iron supplementation or parenteral iron therapy depending on severity. The goal of treatment was to raise hemoglobin levels and replenish iron stores.
Iron deficiency anemia is a common global health problem affecting 30% of the population. It causes decreased work productivity and increases maternal, child, and infant mortality. Good dietary sources of iron include liver, oats, legumes, and cashew nuts. Iron deficiency can be treated with oral iron supplements taken for 8 weeks, while severe cases may require intravenous iron or blood transfusions. Prevention strategies include iron fortification of infant formula and treating iron deficiency in at-risk groups like adolescent females.
Approach to a case of iron defciency anaemiaSachin Adukia
- Anaemia is defined as a reduction in haemoglobin, red blood cell count or haematocrit below normal levels. Iron-deficiency anaemia affects around 2 billion people worldwide including 20-40% of people in India.
- Iron-deficiency anaemia is classified based on the underlying cause such as reduced red blood cell production, increased red blood cell destruction, or loss of red blood cells.
- Diagnosis involves examination of symptoms, signs, and laboratory tests including a blood smear, iron studies, and bone marrow examination. Treatment involves oral or intravenous iron supplementation depending on the severity of the deficiency.
Iron is a mineral that is essential for the formation of hemoglobin in red blood cells. It serves several vital functions in the body including carrying oxygen from the lungs to tissues. Iron deficiency anemia is a condition where the body lacks sufficient red blood cells due to low iron levels, preventing adequate oxygen transport. It is one of the most common nutritional deficiencies worldwide, affecting groups like infants, children, pregnant women, and menstruating women the most. Symptoms include fatigue, pale skin, and shortness of breath.
Megaloblastic anemia is a type of macrocytic anemia caused by a failure of DNA synthesis, resulting in asynchronous maturation of red blood cell nuclei and cytoplasm. The most common causes of megaloblastic anemia are vitamin B12 and folic acid deficiencies. Treatment involves treating the underlying deficiency, with vitamin B12 therapy for B12 deficiency and oral folic acid supplementation for folic acid deficiency. Response to treatment is monitored through improvement of hematological markers and symptoms over 1-8 weeks.
The document discusses iron deficiency anemia, including its definition, symptoms, causes, stages, diagnostic tests, and treatment options. Key points include:
- Iron deficiency anemia is defined as a reduction in hemoglobin concentration below the reference value.
- Symptoms include fatigue, dizziness, and headaches. Specific symptoms like glossitis or koilonychia may also occur.
- Causes include chronic bleeding, decreased iron intake, and increased iron requirements during growth or pregnancy.
- Diagnosis involves blood tests measuring iron levels, iron binding capacity, ferritin, and a bone marrow smear.
- Treatment options include oral or parenteral iron supplementation to restore iron stores over 6-9
Anaemia, or anemia, is defined as an abnormally low number of red blood cells or level of hemoglobin resulting in diminished oxygen carrying capacity. It can result from blood loss, red blood cell destruction, or deficient red blood cell production due to nutritional deficiencies or bone marrow failure. Iron deficiency is a common worldwide cause of anemia affecting people of all ages, which can result from dietary deficiency, blood loss, or increased demands. The manifestations of iron deficiency anemia are related to impaired oxygen transport and include fatigue, paleness, rapid heartbeat, and reduced exercise endurance. Diagnosis involves low hemoglobin and iron levels, while treatment focuses on controlling blood loss, increasing iron intake, and administering iron supplements.
1. Iron deficiency anemia is a condition caused by low levels of iron in the body, which reduces the amount of oxygen carried by red blood cells.
2. Common causes of iron deficiency anemia include blood loss from menstruation or childbirth, a diet low in iron, and an inability to absorb enough iron from food.
3. Symptoms of iron deficiency anemia include fatigue, dizziness, pale skin, headaches, and brittle nails. Treatment involves oral or intravenous iron supplements to replace iron stores in the body.
The document discusses iron metabolism and disorders of iron deficiency. It covers stages of iron deficiency from depleted iron stores to iron deficiency anemia. Symptoms of iron deficiency anemia include fatigue, dizziness, and behavioral disturbances. Diagnosis involves low hemoglobin, mean corpuscular volume and other blood markers. Treatment focuses on oral or parenteral iron supplementation depending on severity and ability to absorb orally.
UAEU - CMHS - Hematology-Oncology Course - MMH 302 - HONC 320. Education material for medical students - It cover basic principles of hematology and oncology, including CAR-T and gene editing. It can be used for study and review. It illustrates main principles of hematology and oncology.
This document provides an overview of hemolytic anemia, including definitions, pathogenesis, classification, clinical features, laboratory findings, and approaches. Hemolytic anemia is characterized by increased red blood cell destruction. It can be hereditary or acquired. Specific hereditary forms discussed include hereditary spherocytosis, elliptocytosis, and pyropoikilocytosis, which are caused by red blood cell membrane defects. Clinical features may include pallor, jaundice, splenomegaly, and gallstones. Laboratory findings aid in diagnosis and include peripheral smear showing abnormal red blood cells, reticulocytosis, and elevated bilirubin. The document also discusses hemolytic anemia evaluation and differential diagnoses.
This document discusses iron deficiency anemia, including its causes, symptoms, signs, and laboratory investigations used to confirm and determine the cause of the condition. Iron deficiency anemia is the most common form of anemia and is caused by inadequate iron intake, blood loss, or malabsorption. Key lab tests to confirm include low hemoglobin, MCV, serum ferritin and transferrin saturation. Tests to determine the underlying cause include stool samples, endoscopy, and imaging of the gastrointestinal tract.
Megaloblastic anemias are caused by impaired DNA synthesis due to vitamin B12 or folate deficiency. The summary examines megaloblastic anemias, including causes such as vitamin B12 or folate metabolism defects, clinical features like pallor and neurological symptoms, investigation findings in peripheral blood and bone marrow showing megaloblasts and macroovalocytes, and treatment involving vitamin B12 or folate supplementation.
Iron deficiency anemia is the most common type of anemia globally, affecting over 1.6 billion people. The highest prevalence is in preschool-age children and non-pregnant women. In India, 71-84% of children and 79% overall are anemic. Iron is essential for hemoglobin and myoglobin and is stored in the liver, with the average person having 3-4 grams total. Dietary factors that inhibit iron absorption include phytates from grains and legumes, tannins, and calcium. Simple adjustments like consuming vitamin C with meals or separating tea from meals by a few hours can enhance iron absorption. Treating conditions like hookworm and malaria can also help reduce iron deficiency anemia
Chloe, a 20-year-old college student, presented with fatigue, cold hands and feet, shortness of breath, and a swollen tongue and pale gums. The case study initially diagnosed her with iron deficiency anemia, which would be confirmed through a complete blood count showing low hemoglobin and red blood cell levels. Additional tests like endoscopy or colonoscopy may be used to check for internal bleeding as a cause. Treatment would involve iron supplements to restore her iron levels, along with a diet high in iron-rich foods.
Ms. T is a 38-year-old woman who presents with a 6-month history of heavy menstrual bleeding and fatigue. Her lab results show low hemoglobin, ferritin, iron, MCV and MCH levels consistent with iron deficiency anemia. Her risk factors include female gender, past pregnancies, long-term NSAID use, and intermenstrual bleeding. She is started on iron supplements to replenish her iron stores, treat her anemia, and resolve her symptoms.
Drug treatment of iron deficiency anaemiaNaser Tadvi
This document discusses iron deficiency anemia and its treatment. It defines anemia and identifies iron deficiency as a common cause. It describes how iron is used to form hemoglobin and the signs and symptoms of iron deficiency anemia. The document outlines dietary iron requirements and food sources of iron. It provides details on oral and parenteral iron therapy, including dosages, formulations, and potential adverse effects. It also discusses intravenous iron preparations and the use of desferrioxamine for acute iron poisoning.
Iron deficiency anemia is highly prevalent globally, affecting over 2 billion people worldwide. It is caused by inadequate iron intake or absorption relative to the body's needs. Symptoms include pallor, fatigue, and behavioral changes in children. Treatment involves oral iron supplementation, though some severe cases require intravenous iron. Prevention strategies center around dietary modification and supplementation programs.
Anaemia is defined as a reduction in haemoglobin, red blood cells or haematocrit below normal levels. Iron-deficiency anaemia (IDA) affects around 2 billion people worldwide. IDA is prevalent in India, affecting 20% of adult males, 40% of non-pregnant females and children, and 80% of pregnant females. IDA is classified based on its underlying cause such as reduced red blood cell production or increased destruction. Oral iron therapy is usually the first line treatment, while blood transfusions or intravenous iron may be used for more severe cases or those who cannot tolerate oral iron. The diagnosis of IDA relies on a low MCV, MCH and iron studies showing low ferritin and transferrin saturation
Iron deficiency anemia is one of the most common medical problems and the most common cause of anemia. It occurs when iron levels and stores in the body are depleted. Symptoms include fatigue, glossitis, angular stomatitis, and nail changes. Laboratory tests show low hemoglobin, MCV, MCHC, serum iron, and ferritin levels. Treatment involves oral or parental iron replacement therapy to replenish iron stores along with treating any underlying causes of blood loss. Parenteral iron is reserved for cases of malabsorption or noncompliance with oral therapy.
Irion defitient and megaloblastic anemiasJasmine John
This document summarizes iron deficiency anemia and megaloblastic anemia. It discusses the causes, symptoms, laboratory findings, treatment, and prognosis of these conditions. Iron deficiency is the most common cause of anemia worldwide and results from inadequate iron intake or absorption. Megaloblastic anemia is caused by vitamin B12 or folate deficiencies and results in abnormal DNA synthesis and large, immature red blood cells. Treatment involves oral or intravenous iron supplementation for iron deficiency and vitamin B12/folate supplementation for megaloblastic anemia.
Anemia is a decreased level of hemoglobin in the blood. It can be classified based on cause or morphology. Common types include iron deficiency anemia, which is caused by inadequate iron intake and is characterized by microcytic hypochromic blood cells. Thalassemia is a genetic disorder of hemoglobin synthesis that results in microcytic anemia. Megaloblastic anemia is caused by vitamin B12 or folate deficiencies and is marked by large, oddly shaped red blood cells. Other normocytic anemias can be due to chronic disease, blood loss, or disorders like aplastic anemia or hemolytic anemia. Investigation of the cause involves blood tests, bone marrow biopsy, and assessing
Anemia is a decreased level of hemoglobin in the blood. It can be classified based on cause or morphology. Morphological types include microcytic (small RBCs), normocytic (normal sized), and macrocytic (large). Common causes of microcytic anemia include iron deficiency and thalassemia. Iron deficiency anemia results from inadequate iron intake or absorption. Thalassemia is a genetic disorder of hemoglobin synthesis. Macrocytic anemias include megaloblastic anemia from vitamin B12 or folate deficiency. Normocytic anemias can be caused by chronic disease, blood loss, or disorders like aplastic anemia or hemolytic anemia.
Iron deficiency anemia is the most common form of anemia globally. It is caused by low iron intake, absorption issues, increased demands, or blood loss. The document discusses iron metabolism, the stages and clinical features of iron deficiency anemia, and laboratory tests to diagnose it. Key tests include low serum iron, ferritin, and saturation with transferrin, along with microcytic indices on CBC. Bone marrow examination may show iron deficiency. Treatment involves iron supplementation.
Hematological diseases primarily affect the blood and blood-forming organs. Examples include anemias like iron deficiency anemia, which occurs when the body does not have adequate iron. Iron is necessary for red blood cell formation to produce hemoglobin. Without enough iron, the body cannot produce sufficient hemoglobin in red blood cells to adequately deliver oxygen to tissues, which can cause anemia. Iron deficiency is commonly caused by blood loss, failure to meet increased iron requirements during growth or pregnancy, or inadequate iron absorption from the diet or gastrointestinal issues. Symptoms include pale skin, fatigue, and shortness of breath. Iron deficiency is treated with oral or intravenous iron supplements to restore iron levels.
The document discusses hematinic agents such as iron, folic acid, and vitamin B12 which are used to treat anemia. It covers the pharmacokinetics of iron absorption and transport, indications for hematinic agents including iron deficiency anemia, drug interactions, side effects, and iron toxicity treatment with chelating agents.
The document discusses hematinic agents such as iron, folic acid, and vitamin B12 which are used to treat anemia. It covers the pharmacokinetics of iron absorption and transport, indications for hematinic use including iron deficiency anemia, drug interactions, side effects, and iron toxicity treatment with chelating agents.
The document discusses hematinic agents such as iron, folic acid, and vitamin B12 which are used to treat anemia. It covers the pharmacokinetics of iron absorption and transport, indications for hematinic agents including iron deficiency anemia, drug interactions, side effects, and iron toxicity treatment with chelating agents.
Iron deficiency anemia develops when iron stores are too low to support normal red blood cell production. It can be caused by inadequate dietary iron, impaired iron absorption, bleeding, or loss of body iron. Diagnosis involves a complete blood count showing microcytic, hypochromic anemia and low serum iron and ferritin levels. Treatment primarily involves oral iron supplementation, while parenteral iron or blood transfusions are reserved for more severe cases. The underlying cause also needs to be addressed to prevent recurrence.
Anemia is a condition characterized by low red blood cell count or hemoglobin levels. It can be caused by inadequate red blood cell production, increased destruction, or blood loss. Common symptoms include fatigue, pallor, and shortness of breath. Iron deficiency anemia is the most common type and results from inadequate iron intake or absorption. It can cause microcytic hypochromic anemia. Vitamin B12 deficiency can cause megaloblastic anemia due to its role in DNA synthesis. It is caused by low intake, malabsorption, or poor utilization and signs include macrocytosis, neurological symptoms, and smooth muscle problems. Diagnosis involves blood tests and treatment depends on the underlying cause.
Erythropoiesis,Anemia,Iron Deficiency Anemia by Dr. Sookun Rajeev KumarDr. Sookun Rajeev Kumar
1. Iron deficiency anemia is caused by inadequate iron intake or absorption leading to decreased hemoglobin and microcytic red blood cells. Symptoms include weakness, fatigue, and pallor.
2. Diagnosis involves blood tests showing low iron, ferritin and saturation and high TIBC. Peripheral smear shows microcytic hypochromic anemia.
3. Treatment is oral iron supplementation though intravenous may be needed in severe cases. Regular intake and monitoring is important to fully replenish iron stores.
Babitha's Notes on anemia's & bleeding disordersBabitha Devu
This note will help you in knowing about childhood anemia's like iron deficiency, SCD etc.. also some of the bleeding disorders are also explained in this.
ANAEMIAS CAUSES PREVENTION AND MANAGEMENT.pptxAndrewSilungwe2
Hematopoiesis is the production of blood cells from stem cells, mainly occurring in the bone marrow. It requires iron, vitamin B12, and folic acid. Deficiencies in these can lead to anemia. Iron deficiency anemia is the most common type and appears as hypochromic microcytic anemia. Oral iron supplementation is usually first-line treatment, while parenteral iron may be used for severe or refractory cases. The goals of treatment are to correct the underlying cause, replace iron stores, and alleviate symptoms of anemia.
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Travel Clinic Cardiff: Health Advice for International TravelersNX Healthcare
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Kosmoderma Academy, a leading institution in the field of dermatology and aesthetics, offers comprehensive courses in cosmetology and trichology. Our specialized courses on PRP (Hair), DR+Growth Factor, GFC, and Qr678 are designed to equip practitioners with advanced skills and knowledge to excel in hair restoration and growth treatments.
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
The skin is the largest organ and its health plays a vital role among the other sense organs. The skin concerns like acne breakout, psoriasis, or anything similar along the lines, finding a qualified and experienced dermatologist becomes paramount.
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
2. Iron in human body
Total Iron in human body averages 4 to 5 grams which is
distributed as:
1. 65% in form of Hb.
2. 4% in form of mayoglobin.
3. 1% in form of heme compunds whcih promote intracelluar
oxidation.
4. 0.1% is combined with protein transferrin in blood plasma.
5. 15%−30% stored for later use,mainly in reticuloendothelial
system of bone marrow and liver parenchymal cells,
principally in form of ferritin
3. Iron transport & metabolism
Fereitin hemosiderin
heme
Free Fe enzymes
(Tissue:liver & RNC of BM)
Transferrin−Fe
Macrophages
Degrading hemoglobin
Free Fe
Hemoglobin
Red cells
Blood loss−0.7mg
daily
In menses
Fe absorbed
(small intestine)
Only regulation
mechanism
Fe excreted−0.6mg
daily
Bilirubin
excreted
6. Regulation of cellular & systemic Iron
homeostasis
hepcidin:25−amino acids peptide
hormone secreted by liver
Increase in Fe stores,
infection, inflammation
or malignancy
ferroportin: sole known cellular Fe
export channel
Fe deficiency,hypoxia,
increased erythropoiesis,
Ineffective erythropoiesis
Iron efflux into plasma from macrophages,
heptocytes
& intestinal enterocytes
+ −
− +
− +
9. Iron deficiency
Iron deficiency is a decrease in the amount of
body iron resulting from a sustained increase
in iron requirements over iron supply.
Iron deficiency reduces the responsiveness of
erythroid progenitors to erythropoitein,apparently
through an Iron−aconitase−isocitrate pathway.
with a lack of Iron, decreased utilization for RBCs
production helps preserve the supply of Iron for
vital functions in other tissues.
10. Epidemiology
Iron deficieny is one of most prevalent forms of
malnutition and so most common anemia worldwide.
Special groups:toddlers, adolescent girls, women of
child−bearing age and some minority groups.
High prevalence of iron deficiency with or without anemia has
been reported among patients with restless legs
syndrome(akathisia).
12. Causes of Iron deficiency
Increased Iron requirements &/or hematopoiesis
1. Growth
2. Pregnancy & lactation
3. Erythropoietin therapy
Increased Iron loss/Blood loss
Gastrointestinal tract, Genitourinary tract, respiratory tract,
blood donation, phlebotomy as treatment for polychythemia
vera
Decreased Iron intake or absorption
1. Dietary insufficiency of bioavailable Iron
2. Impaired absorption of Iron: intestinal malabsorption, gastric
surgery,Iron−refractory Iron deficiency anemia
3. Acute or chronic inflammtion
13.
14. Presenting forms
1. no signs or symptoms coming to medical attention only
because of abnormalities noted on laboratory tests
2. features of underlying disorder responsible for
development of iron dediciency
3. manifestations common to all anemias
4. one or more of signs and symtoms considered highly
specific for iron deficiency,namely, pagophagia(variant of
pica), koilonychia and blue sclerae.
15. Clinical presentation
It depends upon severity of Iron deficiency.
It produce signs & symptoms common to all anemias which are
pallor, palpitations, tinnitus, headache, irritability, weakness,
dizziness, easy fatigability and other vague & nonspecific
complaints.
Iron deficiency produce clinical symptoms independent of
anemia e.g. glosssitis, angular stomatitis, postcricoid
esophageal web or stricture, gastric atrophy.
It has nonhematologic consequences, including impaired
immunity and resistance to infection, diminished exercise
tolerance and work performace and a variety of behavioral and
neuropsychologic abnormalities.
16.
17. Laboratory evaluation of iron status
Direect measures Indirect measures
Fe
deficiency
Fe
overload
BM
Aspirate&
biopsy
MRI
Non−inv
Q.
Flebotomy
Liver biopsy
1. Serum ferritin
2. Serum iron &TIBC
3. Transferrin saturation
4. RBC protoporphyrin
5. Serum level of TRP
no single indicator or combination
of indicators is Ideal for evaluation
of iron status in
all clinical circumstances
18.
19. Stages of Iron deficiency
Negative iron balance/iron depletion: demands for
or loss of iron exceed the body´s ability to absorb
iron from diet and starts Iron store depletion.
Iron deficient erythropoiesis: after the depletion of
Iron store,once transferrin saturation falls to
15−20%, Hb synthesis becomes impaired.
Frank Iron deficiency anemia: both Iron store and
serum Iron depleted and Hb & hematocrit begin to
fall, reflecting iron deficiency anemia,transferrin
saturation at this poit is 10−15% with
hypochromia/microcitosis.
20. Classification of Iron deficiency
un−complicated Iron deficiency:
the characteristic patterns of indicatores of body iron
status because hepcidin production is regulated only
by Fe−stores in a healthy person.
complicated Iron deficiency:
the characteristic pattern of indicators of body iron
status is lost because hepcidin production is
controled by a lot of factors and serum ferritin acute
phase reactant.
21. Tests normal −ve IB IDE IDA
BM store 1−3+ 0 −1+ 0 0
S. ferritin (µg/dl) 50−100 <20 <15 <15
TIBC (µg/dl) 300−360 360˃ 380˃ 400˃
SI (µg/dl) 50 −150 NL <50 <30
Sat:SIx100/TIBC 30−50% NL <20 <10
Sideroblas%(BM) 40−60 NL <10 <10
Protoporfrin(µg/dl) 30−50 NL 100˃ 200˃
RBCs Morphology NL NL NL Micocytic/h
ipocromic
un−complicated iron deficiency
25. un−complicated iron deficiency
Transferrin saturation% : <18%
Serrum ferritin : <15 µg/dl
Red cell protoporphyrin level : 100 µg/dl˃
Serum levels of TRP: 9 µg/dl˃
RBCs morphology: microcytic/hypochromic
Iron deficiency can give reactive thrombocitosis but
leukocyte normal.
26. Complicated iron deficiency
Individualizied the patients because not have specific pattern of iron
depletion due to following reasons.
1. Depending upon clinical circumstances,the effects of inflammation or
erythropoiesis on hepatic hepcidin synthesis may predominate over those of iron
body stores.
2. Malignancy also stimulate hepcidin production.
3. Hypoxia and increased erythropoitic demand inhibit the stimulus.
4. Liver disease and malnutrition may also impair hepcidin expression.
5. Plasma ferritin:acute phase reactant, concentration increase by fever,acute
Infection, rheumatoid arthitis,liver & other tissue damge.
6. Only 2 conditions that may lower plasma ferritin concentration independtly of
decrease of iron stores are hypothyrodism and ascorbate deficiency.
serum TRP is less affected by inflammation, its measurement usually can determine
whether iron store are absent.
27. Differential diagnosis of microcytic
hypochromic anemia
decreased body Iron stores
1. Iron deficiency anemia
Normal or increased body iron stores
1. Anemia of chronic disease
2. Defective absorption,transport/use of iron
3. Disorders of globin synthesis: thalassemia, other
microcytic hemoglobinopathies
4. Disorders of heme synthesis: sideroblastic
anemias(hereditary & acquired)
5. Iron refractory,iron deficiency anemia
6. Atransferrinemia
7. Aceruloplasminemia
8. Divalent metal transporter hemochromatosis with impaired
iron export (type 4A)
9. Heme oxygenase 1 deficiency
28. Diagnosis of microcytic anemia
Tests Iron
def.
inflammati
on
thalassemia siderobla
stic
smear Micro/
hypo
Normal,mi
cro/hypo
Micro/hypo
with
targeting
variable
SI <30 <50 Normal−hig Norma−h
TIBC 360˃ <300 Normal normal
Saturation% <10 10−20 30 −80 30 −80
Ferritin(µg/dl) <15 30−200 50 −300 50 −300
Hb pattern norma normal abnormal normal
29. Diagnosis of microcytic anemia
Diagnosis of Iron deficiency often is confirmed by outcomes of a
therapeutic trail of Iron.
The unequivvocal diagnostic response consists of
1. A reticulocytosis,which begin approximately 3−5 days after adequate
Iron therapy is instituted, reaches a maximum on days 8 to 10 and
then declines.
2. Increase in Hb concentration which should begin shotly after
reticulocyte peak, is invariably present by 3 weeks after iron therapy is
begun and persists untill Hb concentation is restored to normal.
Therapeutic trail merely aids in establishing presence of Iron
deficiency, search for underlying causes of iron deficiency must
continue despite a positive response to therapy.
Difficulties in evaluation of microcytic hypochromic disorders
usually arise when direct assessment of BM iron is unavailable
and diagnosis depends on indirect indicators of Iron status.
30.
31. Treatment of Iron deficiency anemia
Generally iron therapy can be defered untill the underlying
cause of iron lack has been identified.
The goal of therapy is to supply sufficient iron to repair Hb
deficit and replenish storage iron.
For patients with unusual blood loss or malabsortion, specific
diagnostic tests and appropriate therapy take priority.
Types of therapies: oral,parenteral,RBC tranfusion
Types of therapies: oral,parenteral,RBC tranfusion
Adverse reaction of therapies: hemochromatosis (iron overload)
32. Choice of therapy
The severity and cause of iron deficiency anemia will determine
the appropriate approach to treatment.
Oral iron is the treatment of choice for most patients because of
its effectiveness, safety and economy and should always be
given perference over parenteral iron for initial treatment.
Parenteral therapy with risk of adverse reactions should be
reserved for exceptional patient who
1. Remains intolerant of oral iron despite repeated modifications in
dosage regimen.
2. Has iron needs that cannot be met by oral therapy because of
either chronic uncontrollable bleeding or other sources of blood
loss such as hemodialysis or coexisting chronic inflammatory
state.
3. Malabsorbs iron.
Transfusion therapy is reserved for individuals who have symptoms of
anemia, cardiovascular instability, continued and excessive blood loss
from whatever source and require immediate intervention.
33. Oral Iron therapy
Oral Iron preparations: ferrous sulfate, ferrous
fumarate, ferrous gluconate, polysaccharide iron.
Therapy should begin with ferrous iron salt, ferrous
sulfate is most widely used either as tablets containing
60−70mg of iron for adults or as liquid preparation for
children.
Taken separately from meals in 3 or 4 divided doses
and supplying a daily of 150 to 200 mg of elemental iron
in adults or 3 mg per Kg of body weight in children.
Administration between meals maximize absorption.
For milder anemia a single dose of 60mg per day may
be adequate.
34. Oral Iron therapy
Sustained treatment for a period of 6−12 months
after correction of anemia will be necessary to
achieve stores of at least 0.5−1.0 g of iron.
An increase in Hb concentration of at least 2 g/dl
after 3 weeks of therapy generally is used as
criterion for an adequate therapeutic response.
Most patients are able to tolerate oral iron without
difficulty but 10%−20% may have symptoms
attributable to iron,most common side effects are
gastrointestinal.
35. Parenteral Iron therapy
Parenteral preparations: higher and lower molecular weight
iron dextran, sodium ferric gluconate complex, iron sucrose
& ferumoxytol.
Amount of iron need by an individual patient:
Body weight(kg)x2.3x(15−patient´s Hb,g/dl)+500 or 1000mg(for
store)
Infrequent immediate life theatening anaphylactic reactions
constitute the most serious risk associated with use of either IM
or IV iron preparations,may have fatal outcomes.
Delayed but severe serum sickness−like reactions may also
develop with fever, urticaria, denopathy, myalgias and arthralgias.
36. Red cell transfusion
not only do transfusion correct anemia acuetly but
transfused red cells provide a source of iron for
reutilization,assuming they are not lost through
continued bleeding.
37.
38. Bibliography
Basic Principles & practice of Hematology
2013 by Hoffman
Harrison´s principles of internal medicine
Robbins Basic Pathology
Guyton & Hall Text of Medical Physiology